Teva Pharmaceutical Industries (TEVA) Financial Ratios: P/E, ROE & More

Teva Pharmaceutical Industries (TEVA) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Teva Pharmaceutical Industries had a P/E ratio of 23.28, return on equity of 20.8% (up from -28.3%), debt-to-equity of 2.18 (down from 3.18) and a current ratio of 1.04 (up from 0.98). A current ratio of 1.04 means current assets exceed current liabilities.

Teva Pharmaceutical Industries Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	23.28	-	-	-	22.88	-
Forward P/E	-	-	-	-	-	3.76
P/S Ratio	1.90	1.27	0.61	0.67	0.60	0.64
P/B Ratio	4.15	3.67	1.19	1.16	0.85	0.96
Price/FCF	28.59	28.02	11.48	9.53	40.43	16.58
Price/OCF	19.91	16.83	7.06	6.25	11.96	8.70
PEG Ratio	-	-	-	-	-	0.54
Enterprise Value Ratios
EV/Revenue	2.77	2.25	1.79	2.02	2.06	2.15
EV/EBITDA	9.63	8.41	6.52	7.58	7.41	7.77
EV/EBIT	12.07	11.05	8.88	11.30	10.60	11.73
EV/FCF	41.56	49.75	33.60	28.86	138.35	56.18
Profitability & Returns
Return on Equity (ROE)	20.79%	-28.30%	-7.35%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	6.17%	5.09%	4.55%	3.63%	3.92%	3.53%
Return on Invested Capital (ROIC)	18.73%	14.74%	12.10%	8.85%	6.18%	4.77%
Return on Capital Employed (ROCE)	14.50%	12.70%	10.20%	8.20%	8.40%	8.20%
Leverage & Solvency Ratios
Debt/Equity	2.18	3.18	2.50	2.52	2.10	2.40
Debt/EBITDA	3.39	3.98	4.53	5.26	5.19	5.57
Debt/FCF	15.01	24.28	24.08	20.80	99.97	41.59
Liquidity Ratios
Current Ratio	1.04	0.98	1.02	1.05	1.14	0.99
Quick Ratio	0.54	0.50	0.54	0.57	0.61	0.51
Efficiency Ratios
Asset Turnover	0.43	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.69	2.41	2.09	2.08	2.02	2.02
Yield & Distribution Ratios
Earnings Yield	4.30%	-7.81%	-5.78%	-24.63%	4.37%	-37.73%
FCF Yield	3.50%	3.57%	8.71%	10.49%	2.47%	6.03%
Buyback Yield	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Return	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Teva Pharmaceutical Industries Financial Ratios

What is Teva Pharmaceutical Industries's P/E ratio?

Teva Pharmaceutical Industries's P/E ratio was 23.28 for fiscal 2025 (period ended Dec 31, 2025).

What is Teva Pharmaceutical Industries's return on equity?

Teva Pharmaceutical Industries's return on equity (ROE) was 20.8% for fiscal 2025 (period ended Dec 31, 2025). It was -28.3% a year earlier.

What is Teva Pharmaceutical Industries's debt-to-equity ratio?

Teva Pharmaceutical Industries's debt-to-equity ratio was 2.18 for fiscal 2025 (period ended Dec 31, 2025). It was 3.18 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition